Overall, a stability of GPL was observed in 55 patients (70%), a progression to more severe lesion in 11 patients (14%, including 2 patients with gastric adenocarcinoma), and a regression in 13 patients (16%, including 8 to normal gastric mucosa and 5 to non-AG). Here, IL31RA is linked to gastric adenocarcinoma.